HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Zheng Selected Research

Ovariectomy (Oophorectomy)

1/2021Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 Signaling.
1/2019Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
12/2018Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Zheng Research Topics

Disease

51Neoplasms (Cancer)
12/2022 - 03/2005
11Neoplasm Metastasis (Metastasis)
12/2022 - 03/2009
11Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2007
10Infections
01/2022 - 11/2004
9Lung Neoplasms (Lung Cancer)
12/2022 - 07/2012
9Alzheimer Disease (Alzheimer's Disease)
07/2022 - 02/2006
9Inflammation (Inflammations)
10/2021 - 01/2007
8Memory Disorders (Memory Loss)
07/2022 - 12/2016
8Hepatocellular Carcinoma (Hepatoma)
03/2022 - 01/2012
8Osteoporosis
01/2022 - 12/2018
7Carcinoma (Carcinomatosis)
05/2021 - 07/2006
6Rheumatoid Arthritis
03/2022 - 11/2014
6Breast Neoplasms (Breast Cancer)
01/2022 - 12/2009
6Body Weight (Weight, Body)
01/2022 - 06/2018
5Chronic Renal Insufficiency
01/2021 - 01/2019
5Fibrosis (Cirrhosis)
01/2021 - 02/2011
5Carcinogenesis
01/2018 - 07/2006
5Stomach Neoplasms (Stomach Cancer)
04/2016 - 03/2009
5Chronic Hepatitis B
03/2015 - 08/2010
5Colonic Neoplasms (Colon Cancer)
11/2014 - 07/2008
5Neuroblastoma
01/2013 - 02/2006
5Amyloid Plaque
01/2013 - 02/2006
4Hyperplasia
03/2021 - 01/2012
4Obesity
01/2020 - 09/2012
4Hyperoxia
12/2011 - 02/2006
3Tuberculosis (Tuberculoses)
07/2022 - 01/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022 - 12/2017
3Thalassemia
04/2022 - 01/2010
3Hepatitis
01/2022 - 02/2010
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 10/2021
3Pain (Aches)
08/2021 - 04/2017
3Esophageal Neoplasms (Esophageal Cancer)
08/2021 - 02/2017
3Glioblastoma (Glioblastoma Multiforme)
04/2021 - 07/2010
3COVID-19
12/2020 - 01/2020
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016 - 09/2013
3Prostatic Neoplasms (Prostate Cancer)
01/2013 - 03/2005
3Non-alcoholic Fatty Liver Disease
01/2012 - 05/2009
2Azoospermia
11/2022 - 12/2009
2Dysbiosis
08/2022 - 01/2022
2Rheumatic Diseases (Rheumatism)
06/2022 - 08/2018
2Type 2 Diabetes Mellitus (MODY)
04/2022 - 01/2016
2Wounds and Injuries (Trauma)
01/2022 - 01/2017
2Colitis
01/2022 - 01/2018
2Bone Resorption
10/2021 - 12/2018

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
12/2022 - 11/2004
17Pharmaceutical PreparationsIBA
06/2022 - 01/2007
8MicroRNAs (MicroRNA)IBA
01/2022 - 01/2010
8Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2010
7CytokinesIBA
01/2022 - 01/2016
6RNA (Ribonucleic Acid)IBA
09/2021 - 12/2014
6Peptides (Polypeptides)IBA
03/2021 - 01/2013
5Oxygen (Dioxygen)IBA
01/2022 - 02/2006
5Protein HydrolysatesFDA Link
03/2021 - 12/2017
5AntioxidantsIBA
02/2020 - 03/2008
5Amyloid beta-PeptidesIBA
09/2012 - 02/2006
4Circular RNAIBA
11/2022 - 10/2018
4Biological ProductsIBA
08/2022 - 05/2013
4Hemoglobins (Hemoglobin)IBA
04/2022 - 08/2013
4EnzymesIBA
03/2022 - 02/2010
4Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 01/2017
4CateninsIBA
09/2018 - 11/2010
3Messenger RNA (mRNA)IBA
04/2022 - 06/2007
3Neuroprotective AgentsIBA
03/2021 - 10/2018
3Scopolamine (Hyoscine)FDA Link
03/2021 - 12/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 12/2011
3Lipase (Acid Lipase)FDA Link
01/2021 - 07/2015
3salicylhydroxamic acid (SHAM)IBA
07/2020 - 07/2010
3Hypoglycemic Agents (Hypoglycemics)IBA
02/2020 - 01/2016
3AdenineFDA LinkGeneric
01/2020 - 01/2019
3Therapeutic UsesIBA
12/2019 - 12/2014
3Amyloid (Amyloid Fibrils)IBA
01/2018 - 12/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 08/2010
3Glutathione (Reduced Glutathione)IBA
04/2016 - 07/2008
3Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 07/2010
3Lamivudine (Epivir)FDA Link
03/2015 - 02/2011
3adefovir dipivoxil (Hepsera)FDA Link
03/2015 - 02/2011
3CaspasesIBA
01/2015 - 10/2011
3Cadherins (E-Cadherin)IBA
10/2014 - 07/2006
3Hepatitis B e AntigensIBA
07/2014 - 08/2010
3Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA
01/2012 - 03/2009
2Small Interfering RNA (siRNA)IBA
12/2022 - 01/2012
2Ubiquitin-Specific ProteasesIBA
12/2022 - 01/2021
2MineralsIBA
07/2022 - 12/2016
2Tyrosine (L-Tyrosine)FDA Link
04/2022 - 10/2019
2Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 05/2021
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2016
2Protein Isoforms (Isoforms)IBA
01/2022 - 01/2021
2PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2022 - 01/2017
2RepSoxIBA
11/2021 - 12/2018
2Dopamine (Intropin)FDA LinkGeneric
10/2021 - 01/2021
2Serum AlbuminIBA
08/2021 - 01/2021

Therapy/Procedure

18Therapeutics
01/2022 - 12/2009
10Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2022 - 11/2017
3Drug Therapy (Chemotherapy)
03/2022 - 07/2012
3Ovariectomy (Oophorectomy)
01/2021 - 12/2018
3Oral Administration
07/2020 - 09/2019
3Radiotherapy
01/2020 - 09/2013
3Lasers (Laser)
01/2019 - 01/2013
2Stents
08/2021 - 08/2021
2Gastrostomy
08/2021 - 01/2015